Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 598 articles:
HTML format



Single Articles


    September 2022
  1. AHLERS MJ, Srivastava PK, Basir MB, O'Neill WW, et al
    Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30390.
    PubMed     Abstract available


  2. SETO AH, Long VJ
    Should doctors replace machines in prehospital electrocardiogram interpretation?
    Catheter Cardiovasc Interv. 2022;100:304-305.
    PubMed    


  3. MUSUMECI G, Civera S
    When not to treat could be the best option.
    Catheter Cardiovasc Interv. 2022;100:338-339.
    PubMed     Abstract available


  4. BUTMAN SM
    Variability in healthcare delivery: It is never a good thing.
    Catheter Cardiovasc Interv. 2022;100:317-318.
    PubMed     Abstract available


  5. VON LEWINSKI D, Herold L, Stoffel C, Patzold S, et al
    PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.
    Catheter Cardiovasc Interv. 2022;100:319-327.
    PubMed     Abstract available


  6. ALTSTIDL JM, Achenbach S, Marwan M, Trobs M, et al
    Comparison of adenosine-independent pressure indices to fractional flow reserve in stent-jailed bifurcation side branches.
    Catheter Cardiovasc Interv. 2022;100:369-377.
    PubMed     Abstract available


    August 2022
  7. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    PubMed     Abstract available


  8. DI MARIO C, Kucukseymen S
    Second generation drug eluting stent: The longer, the better?
    Catheter Cardiovasc Interv. 2022;100:188-189.
    PubMed    


  9. GUO J, Ning Y, Wu S, Zhang F, et al
    Risk factors for in-stent restenosis after vertebral artery stenting of V1 segment: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;100:279-289.
    PubMed     Abstract available


  10. MENNUNI MG, Solli M, Galiffa V, Patti G, et al
    Unmasking of a significant left main stenosis in a patient with high left ventricular pressures.
    Catheter Cardiovasc Interv. 2022;100:216-218.
    PubMed     Abstract available


  11. GAUTIER A, Hovasse T, Arroyo D, Unterseeh T, et al
    Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
    Catheter Cardiovasc Interv. 2022;100:179-187.
    PubMed     Abstract available


    July 2022
  12. MUSTO C, Scappaticci M, Biondi-Zoccai G, De Felice F, et al
    Instantaneous wave-free ratio-guided revascularization of nonculprit lesions in STEMI patients with multivessel coronary disease: The WAVE registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30342.
    PubMed     Abstract available


  13. TRIANTAFYLLIS AS, van Nunen LX, Lesizza P, Pagourelias ED, et al
    Angiographic predictors of aberrant circumflex artery during cardiac catheterization.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30322.
    PubMed     Abstract available


  14. OKUYA Y, Gohil K, Moussa ID
    Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jul 5. doi: 10.1002/ccd.30304.
    PubMed     Abstract available


  15. SHELDON M, Blankenship JC
    STEMI in nonagenarians: Never too old.
    Catheter Cardiovasc Interv. 2022;100:17-18.
    PubMed    


  16. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    PubMed    


  17. DI SERAFINO L, Esposito G
    May FFR-guided PCI save lives?: Commentary on: "Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry".
    Catheter Cardiovasc Interv. 2022;100:49-50.
    PubMed    


  18. KALYANASUNDARAM A, Seth A
    Retrograde CTO PCI-the final frontier-challenges and outcomes.
    Catheter Cardiovasc Interv. 2022;100:28-29.
    PubMed    


  19. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    PubMed    


  20. ADJEDJ J, Morelle JF, Saint Etienne C, Fichaux O, et al
    Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry.
    Catheter Cardiovasc Interv. 2022;100:40-48.
    PubMed     Abstract available


  21. KUMAR K, Coonse K, Zakhary B, Cigarroa JE, et al
    Novel method for left ventricular unloading utilizing percutaneous pulmonary artery drainage in cardiorespiratory failure due to COVID-19 infection.
    Catheter Cardiovasc Interv. 2022;100:175-178.
    PubMed     Abstract available


  22. HIRSCH K, Yogeswaran V, Dean LS
    Spontaneous coronary artery dissection and exogenous estrogen in a transgender female.
    Catheter Cardiovasc Interv. 2022;100:96-99.
    PubMed     Abstract available


  23. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    PubMed     Abstract available


  24. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    PubMed     Abstract available


    June 2022
  25. FAOUR A, Cherrett C, Gibbs O, Lintern K, et al
    Utility of prehospital electrocardiogram interpretation in ST-segment elevation myocardial infarction utilizing computer interpretation and transmission for interventional cardiologist consultation.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30300.
    PubMed     Abstract available


  26. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    PubMed     Abstract available


  27. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    PubMed     Abstract available


  28. THAKKER R, Jneid H
    Sex-related differences in cardiogenic shock: Can we do better in women?
    Catheter Cardiovasc Interv. 2022;99:1996-1997.
    PubMed    


  29. GRINES CL, Kern MJ
    Should we use invasive fractional flow reserve (FFR), imaging, or both to determine the significance of a "borderline" lesion?
    Catheter Cardiovasc Interv. 2022;99:2016-2017.
    PubMed    


  30. SIMSEK B, Brilakis ES
    Why double-kissing crush should be preferred over culotte for two-stent bifurcation stenting.
    Catheter Cardiovasc Interv. 2022;99:2006-2007.
    PubMed    


  31. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    PubMed     Abstract available


  32. OSMAN M, Syed M, Kheiri B, Bianco C, et al
    Age stratified sex-related differences in incidence, management, and outcomes of cardiogenic shock.
    Catheter Cardiovasc Interv. 2022;99:1984-1995.
    PubMed     Abstract available


  33. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2022;99:1965-1975.
    PubMed     Abstract available


  34. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    PubMed     Abstract available


    May 2022
  35. KLEIN LW, Anderson HV, Cigarroa J
    Integrating shared decision-making in coronary revascularization with quality assurance programs.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30222.
    PubMed    


  36. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    PubMed     Abstract available


  37. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    PubMed     Abstract available


  38. ISMAYL M, Machanahalli Balakrishna A, Walters RW, Pajjuru VS, et al
    In-hospital mortality and readmission after ST-elevation myocardial infarction in nonagenarians: A nationwide analysis from the United States.
    Catheter Cardiovasc Interv. 2022 May 14. doi: 10.1002/ccd.30227.
    PubMed     Abstract available


  39. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    PubMed     Abstract available


  40. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    PubMed     Abstract available


  41. MA W, Wang Q, Wang B, Wang C, et al
    Novel predictors of stent under-expansion regarding calcified coronary lesions assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1473-1481.
    PubMed     Abstract available


  42. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    PubMed     Abstract available


  43. HE J, Zhang D, Zhang R, Wang H, et al
    Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system in unprotected left main bifurcation.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1465-1472.
    PubMed     Abstract available


  44. GUAN C, Geng L, Zhang R, You J, et al
    Long-term prognostic value of dynamic function assessment of intermediate coronary lesion with computational physiology.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1386-1394.
    PubMed     Abstract available


  45. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    PubMed     Abstract available


  46. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    PubMed     Abstract available


    April 2022
  47. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    PubMed     Abstract available


  48. BALDETTI L, Beneduce A, Boccellino A, Pagnesi M, et al
    Bedside intra-aortic balloon pump insertion in cardiac intensive care unit: A single-center experience.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30197.
    PubMed     Abstract available


  49. PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
    Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
    PubMed     Abstract available


  50. FERNANDEZ-PEREGRINA E, Ahmad H, Mintz GS, Garcia-Garcia HM, et al
    When coronary imaging and physiology are discordant, how best to manage coronary lesions? An appraisal of the clinical evidence.
    Catheter Cardiovasc Interv. 2022 Apr 4. doi: 10.1002/ccd.30186.
    PubMed     Abstract available


  51. FABRIS E, Menzio S, Gregorio C, Pezzato A, et al
    Effect of prehospital treatment in STEMI patients undergoing primary PCI.
    Catheter Cardiovasc Interv. 2022;99:1500-1508.
    PubMed     Abstract available


  52. LEMOR A, Dabbagh MF, Cohen D, Villablanca P, et al
    Rates and impact of vascular complications in mechanical circulatory support.
    Catheter Cardiovasc Interv. 2022;99:1702-1711.
    PubMed     Abstract available


  53. RIVERO F, Marco V, Biccire FG, Budassi S, et al
    The double injection technique to improve visualization of severe coronary lesions with optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99:1511-1517.
    PubMed     Abstract available


  54. SONCK J, Mizukami T, Johnson NP, Nagumo S, et al
    Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks.
    Catheter Cardiovasc Interv. 2022;99:1518-1525.
    PubMed     Abstract available


  55. KHOKHAR AA, Zelias A, Zlahoda-Huzior A, Dudek D, et al
    Complication during robotic-PCI: Iatrogenic guiding catheter dissection.
    Catheter Cardiovasc Interv. 2022;99:1526-1528.
    PubMed     Abstract available


  56. BANSAL A, Jaber WA, Reed GW, Puri R, et al
    Surgical versus medical management of infective endocarditis after TAVR.
    Catheter Cardiovasc Interv. 2022;99:1592-1596.
    PubMed     Abstract available


    March 2022
  57. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    PubMed     Abstract available


  58. TONOMURA D, Shimada Y, Yamanaka Y, Terashita K, et al
    Laser vaporization of atherothrombotic burden before drug-coated balloon application in ST-segment elevation myocardial infarction: Two-year outcomes of the laser-DCB trial.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30149.
    PubMed     Abstract available


  59. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    PubMed     Abstract available


  60. PARIKH PB, Reilly JP
    Outcomes with early opioid administration in acute coronary syndromes: Does sex matter?
    Catheter Cardiovasc Interv. 2022;99:996-997.
    PubMed    


  61. TARANTINI G, Cardaioli F
    Bioresorbable scaffolds: zebras are not striped horses.
    Catheter Cardiovasc Interv. 2022;99:1084-1085.
    PubMed    


  62. PATEL NJ, Heuser RR
    Physiologic liquid plumber: A novel treatment to facilitate crossing of chronic total occlusions.
    Catheter Cardiovasc Interv. 2022;99:1074.
    PubMed    


  63. GRINES CL, Marshall JJ
    Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease.
    Catheter Cardiovasc Interv. 2022;99:968-969.
    PubMed    


  64. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    PubMed    


  65. SPIRITO A, Mehran R
    Elderly patients with acute myocardial infarction: Targeted or complete revascularization?
    Catheter Cardiovasc Interv. 2022;99:979-980.
    PubMed    


  66. DANGAS G, Garg A
    Double kissing crush stenting: No pain, no gain?
    Catheter Cardiovasc Interv. 2022;99:1045-1046.
    PubMed    


  67. SIMSEK B, Kostantinis S, Karacsonyi J, Vemmou E, et al
    Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;99:1038-1044.
    PubMed     Abstract available


  68. BISCAGLIA S, Erriquez A, Serenelli M, D'Ascenzo F, et al
    Complete versus culprit-only strategy in older MI patients with multivessel disease.
    Catheter Cardiovasc Interv. 2022;99:970-978.
    PubMed     Abstract available


  69. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    PubMed     Abstract available


  70. HILLERSON D, Whiteside HL, Dugan AJ, Coots RD, et al
    Predicting mortality in nonsurgical patients before cannulation for veno-arterial extracorporeal life support: Development and validation of the LACT-8 score.
    Catheter Cardiovasc Interv. 2022;99:1115-1124.
    PubMed     Abstract available


  71. TAKAHASHI T, Nishi T, Zimmermann FM, Granada JF, et al
    Clinical validation of a novel simplified offline tool for SYNTAX score calculation.
    Catheter Cardiovasc Interv. 2022;99:1366-1368.
    PubMed    


  72. GRAHAM JJ, Bagai A, Wijeysundera H, Weisz G, et al
    Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial.
    Catheter Cardiovasc Interv. 2022;99:1065-1073.
    PubMed     Abstract available


  73. JENTZER JC, Soussi S, Lawler PR, Kennedy JN, et al
    Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population.
    Catheter Cardiovasc Interv. 2022;99:1006-1014.
    PubMed     Abstract available


  74. MEJIA-RENTERIA H, Faria D, Lee JM, Lee SH, et al
    Association between patient age, microcirculation, and coronary stenosis assessment with fractional flow reserve and instantaneous wave-free ratio.
    Catheter Cardiovasc Interv. 2022;99:1104-1114.
    PubMed     Abstract available


  75. NAN TIE E, Fernando H, Nehme Z, Dinh D, et al
    Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes.
    Catheter Cardiovasc Interv. 2022;99:989-995.
    PubMed     Abstract available


  76. HANSEN KN, Maeng M, Raungaard B, Engstrom T, et al
    Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
    Catheter Cardiovasc Interv. 2022;99:1095-1103.
    PubMed     Abstract available


  77. BARKHOLT TO, Neghabat O, Holck EN, Andreasen LN, et al
    Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Catheter Cardiovasc Interv. 2022;99:1075-1083.
    PubMed     Abstract available


  78. WILLIAMS T, Mittal A, Karageorgiev D, Iniguez Romo A, et al
    Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry.
    Catheter Cardiovasc Interv. 2022;99:961-967.
    PubMed     Abstract available


    February 2022
  79. ARCHILLETTI F, Giuliani L, Dangas GD, Ricci F, et al
    Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Feb 19. doi: 10.1002/ccd.30137.
    PubMed     Abstract available


  80. SUI Y, Yang M, Xu Y, Wu N, et al
    Diagnostic performance of intravascular ultrasound-based fractional flow reserve versus angiography-based quantitative flow ratio measurements for evaluating left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30078.
    PubMed     Abstract available


  81. VALVO R, Costa G, Tamburino C, Barbanti M, et al
    Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
    PubMed     Abstract available


  82. HANNA EB, Rossen J, Eustes AS, Dayal S, et al
    Heavy lone coronary artery thrombosis treated by stent retriever, in the setting of COVID-19 infection.
    Catheter Cardiovasc Interv. 2022;99:457-461.
    PubMed     Abstract available


  83. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    PubMed     Abstract available


  84. KHAN AA, Dangas G
    Is cardiac surgery backup required for left main stenting?
    Catheter Cardiovasc Interv. 2022;99:607-608.
    PubMed    


  85. ALASNAG M
    Sound and light editorial: The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2022;99:674-675.
    PubMed    


  86. TARANTINI G, Cardaioli F
    Coronary complete revascularization strategy: A puzzle still hard to complete.
    Catheter Cardiovasc Interv. 2022;99:639-640.
    PubMed    


  87. GOLDSTEIN JA, Mehta NK
    Extent of coronary atherosclerosis and ischemic myocardium foment sudden cardiac death.
    Catheter Cardiovasc Interv. 2022;99:812-813.
    PubMed    


  88. MARCHESE N, Barbato E, Di Gioia G, Stanislao M, et al
    Intracoronary pressures to predict myocardial viability in patients with ischemic left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2022;99:271-279.
    PubMed     Abstract available


  89. LOW RJB, Khoo DZL, Ong PJL
    Case report: A novel application of the MicroVascular Plug (MVP) in treating distal coronary perforation.
    Catheter Cardiovasc Interv. 2022;99:502-507.
    PubMed     Abstract available


  90. HIDALGO F, Gonzalez-Manzanares R, Ojeda S, Benito-Gonzalez T, et al
    Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
    Catheter Cardiovasc Interv. 2022;99:489-496.
    PubMed     Abstract available


  91. XU R, Shi Y, Chang S, Qin Q, et al
    Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2022;99:226-233.
    PubMed     Abstract available


  92. LEE K, Lee PH, Lee SW, Kwon O, et al
    Primary versus rescue retrograde approach for chronic total coronary occlusion.
    Catheter Cardiovasc Interv. 2022;99:219-225.
    PubMed     Abstract available


  93. FEENSTRA RGT, van Lavieren MA, Echavarria-Pinto M, Wijntjens GW, et al
    Respiration-related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration.
    Catheter Cardiovasc Interv. 2022;99:844-852.
    PubMed     Abstract available


  94. KANDZARI DE, Alaswad K, Jaffer FA, Brilakis E, et al
    Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
    Catheter Cardiovasc Interv. 2022;99:263-270.
    PubMed     Abstract available


  95. KANDZARI DE, Kirtane AJ, Mehran R, Price MJ, et al
    Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Catheter Cardiovasc Interv. 2022;99:583-592.
    PubMed     Abstract available


  96. CUENIN L, Honton B, Aminfar F, Meyer P, et al
    Head to head comparison of quantitative flow ratio using 4-French and 6-French catheters versus fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:746-753.
    PubMed     Abstract available


  97. WIEBE J, Hofmann FJ, West N, Baumbach A, et al
    Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
    Catheter Cardiovasc Interv. 2022;99:533-540.
    PubMed     Abstract available


  98. NOGIC J, Nerlekar N, Soon K, Freeman M, et al
    Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry.
    Catheter Cardiovasc Interv. 2022;99:554-562.
    PubMed     Abstract available


  99. EBERLI FR, Stoll HP, Urban P, Morice MC, et al
    Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
    Catheter Cardiovasc Interv. 2022;99:593-600.
    PubMed     Abstract available


  100. KOSMOPOULOS M, Bartos JA, Raveendran G, Goslar T, et al
    Coronary artery disease burden relation with the presentation of acute cardiac events and ventricular fibrillation.
    Catheter Cardiovasc Interv. 2022;99:804-811.
    PubMed     Abstract available


  101. HUSSAIN Y, Gaston S, Kluger J, Shah T, et al
    Long term outcomes of ultrathin versus standard thickness second-generation drug eluting stents: Meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2022;99:563-574.
    PubMed     Abstract available


  102. G TOTH G, Collet C, Langhoff Thuesen A, Mizukami T, et al
    Influence of fractional flow reserve on grafts patency: Systematic review and patient-level meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:730-735.
    PubMed     Abstract available


  103. MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
    Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:723-729.
    PubMed     Abstract available


  104. HARDING SA, Webber B, Fairley S, Ormiston JA, et al
    Real-time intravascular ultrasound guidance: A novel technique for accurate placement of ostial stents.
    Catheter Cardiovasc Interv. 2022;99:699-705.
    PubMed     Abstract available


  105. HAKEEM A, Hou L, Shah K, Agarwal SK, et al
    Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry.
    Catheter Cardiovasc Interv. 2022;99:714-722.
    PubMed     Abstract available


  106. SCARSINI R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, et al
    Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
    Catheter Cardiovasc Interv. 2022;99:329-339.
    PubMed     Abstract available


  107. OSMAN M, Ghaffar YA, Osman K, Kheiri B, et al
    Gender-based outcomes of coronary bifurcation stenting: A report from the National Readmission Database.
    Catheter Cardiovasc Interv. 2022;99:433-439.
    PubMed     Abstract available


  108. VAN HEMERT ND, Rozemeijer R, Voskuil M, Stein M, et al
    Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    Catheter Cardiovasc Interv. 2022;99:366-372.
    PubMed     Abstract available


  109. IQBAL MB, Moore PT, Nadra IJ, Robinson SD, et al
    Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2022;99:627-638.
    PubMed     Abstract available


  110. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    PubMed     Abstract available


  111. SAITO Y, Wijns W, Baumbach A, Xu B, et al
    Differential impact of abluminal groove-filled biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent on and off dual antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;99:357-365.
    PubMed     Abstract available


    January 2022
  112. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    PubMed     Abstract available


  113. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    PubMed     Abstract available


  114. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    PubMed     Abstract available


  115. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    PubMed     Abstract available


  116. YUAN S, He J, Cai Z, Zhang R, et al
    Intra-aortic balloon pump in cardiogenic shock: A propensity score matching analysis.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30102.
    PubMed     Abstract available


  117. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    PubMed     Abstract available


  118. LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
    Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
    PubMed     Abstract available


  119. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    PubMed     Abstract available


  120. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    PubMed     Abstract available


  121. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    PubMed     Abstract available


  122. TARANTINI G, Rodino G
    The role of Impella percutaneous left ventricular assist device in the management of cardiogenic shock: A matter of where and when.
    Catheter Cardiovasc Interv. 2022;99:48-49.
    PubMed    


  123. SPIRITO A, Mehran R
    Prolonged dual antiplatelet therapy in selected patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;99:114-115.
    PubMed    


  124. IMPROTA R, Scarparo P, Wilschut J, Wolff Q, et al
    Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.
    Catheter Cardiovasc Interv. 2022;99:88-97.
    PubMed     Abstract available


  125. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;99:98-113.
    PubMed     Abstract available


  126. NOURI SN, Malick W, Masoumi A, Fried JA, et al
    Impella percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: A retrospective analysis from a tertiary academic medical center.
    Catheter Cardiovasc Interv. 2022;99:37-47.
    PubMed     Abstract available


    December 2021
  127. DEMIR OM, Little CD, Jabbour R, Rahman H, et al
    Impact of COVID-19 pandemic on the management of nonculprit lesions in patients presenting with ST-elevation myocardial infarction: Outcomes from the pan-London heart attack centers.
    Catheter Cardiovasc Interv. 2021 Dec 30. doi: 10.1002/ccd.30056.
    PubMed     Abstract available


  128. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2021 Dec 28. doi: 10.1002/ccd.30049.
    PubMed     Abstract available


  129. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    PubMed     Abstract available


  130. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    PubMed     Abstract available


  131. KAFKAS N, Dragasis S, Mantis C, Floros G, et al
    Myocardial infarction with non obstructive coronary arteries complicated with ventricular septal rupture: A case report and literature review.
    Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30028.
    PubMed     Abstract available


  132. TOMEY MI, Dangas GD
    Risk prediction in cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;98:1285-1286.
    PubMed    


  133. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    PubMed    


  134. KLEIN LW, Tamis-Holland J, Kirtane AJ, Anderson HV, et al
    The appropriate use criteria: Improvements for its integration into real world clinical practice.
    Catheter Cardiovasc Interv. 2021;98:1349-1357.
    PubMed     Abstract available


  135. MARASHLY Q, Taleb I, Kyriakopoulos CP, Dranow E, et al
    Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score.
    Catheter Cardiovasc Interv. 2021;98:1275-1284.
    PubMed     Abstract available


  136. CHICHAREON P, van Klaveren D, Modolo R, Kogame N, et al
    Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
    Catheter Cardiovasc Interv. 2021;98:1287-1297.
    PubMed     Abstract available


  137. VERDOIA M, Rolla R, Pergolini P, Gioscia R, et al
    Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Catheter Cardiovasc Interv. 2021;98:1309-1316.
    PubMed     Abstract available


  138. ABHYANKAR A, Abizaid A, Chamie D, Patel G, et al
    Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:1335-1342.
    PubMed     Abstract available


  139. KOUTOUZIS M, Liontou C, Xenogiannis I, Tajti P, et al
    Same day discharge after chronic total occlusion interventions: A single center experience.
    Catheter Cardiovasc Interv. 2021;98:1232-1239.
    PubMed     Abstract available


    November 2021
  140. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    PubMed     Abstract available


  141. AKL E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, et al
    First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30001.
    PubMed     Abstract available


  142. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    PubMed     Abstract available


  143. VALLURUPALLI S, Salehi N, Agarwal S, Hasan R, et al
    Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention.
    Catheter Cardiovasc Interv. 2021;98:1021-1026.
    PubMed     Abstract available


  144. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    PubMed    


  145. MEHTA S, Grines CL, Botelho R, Fernandez F, et al
    STEMI telemedicine for 100 million lives.
    Catheter Cardiovasc Interv. 2021;98:1066-1071.
    PubMed     Abstract available


  146. CERRATO E, Belliggiano D, Quadri G, Erriquez A, et al
    Anatomical and functional healing after resorbable magnesium scaffold implantation in human coronary vessels: A combined optical coherence tomography and quantitative flow ratio analysis.
    Catheter Cardiovasc Interv. 2021;98:1038-1046.
    PubMed     Abstract available


  147. JACKEL M, Zotzmann V, Wengenmayer T, Duerschmied D, et al
    Incidence and predictors of delirium on the intensive care unit after acute myocardial infarction, insight from a retrospective registry.
    Catheter Cardiovasc Interv. 2021;98:1072-1081.
    PubMed     Abstract available


  148. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    PubMed    


  149. KIRRESH A, Candilio L, Stone GW
    Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30008.
    PubMed     Abstract available


  150. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    PubMed     Abstract available


  151. SCARSINI R, Fezzi S, Pesarini G, Del Sole PA, et al
    Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy.
    Catheter Cardiovasc Interv. 2021 Nov 10. doi: 10.1002/ccd.30007.
    PubMed     Abstract available


  152. QUESADA O, Henry TD
    Functional coronary angiography for coronary microvascular function: the time has come!
    Catheter Cardiovasc Interv. 2021;98:836-837.
    PubMed    


  153. KALETA FP, Gilchrist IC
    PRECISE-DAPT: A tool to measure if Afib patients may risk being stretched too thin.
    Catheter Cardiovasc Interv. 2021;98:846-847.
    PubMed    


  154. KUMAR S, Mehta PK, Eshtehardi P, Hung OY, et al
    Functional coronary angiography in symptomatic patients with no obstructive coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:827-835.
    PubMed     Abstract available


  155. TOELG R, Slagboom T, Waltenberger J, Lefevre T, et al
    Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
    Catheter Cardiovasc Interv. 2021;98:848-856.
    PubMed     Abstract available


  156. GUPTA A, Seth A
    Oral anticoagulants for coronary artery aneurysm: For few or for all?
    Catheter Cardiovasc Interv. 2021;98:872-873.
    PubMed    


  157. WANI O, Butman SM
    Auf wiedersehen coronary stenosis? Not so fast mein Herr.
    Catheter Cardiovasc Interv. 2021;98:863.
    PubMed    


  158. PARK H, Kang DY, Kim SO, Lee J, et al
    Ten-year outcomes of early generation sirolimus- versus paclitaxel-eluting stents in patients with left main coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E705-E714.
    PubMed     Abstract available


  159. NOGUCHI M, Dohi T, Okazaki S, Matsumura M, et al
    Comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:E677-E686.
    PubMed     Abstract available


  160. CANDREVA A, Mizukami T, Sonck J, Munhoz D, et al
    Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients.
    Catheter Cardiovasc Interv. 2021;98:E647-E654.
    PubMed     Abstract available


  161. FAGEL ND, Amoroso G, Rabbering T, Gescher F, et al
    One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
    Catheter Cardiovasc Interv. 2021;98:E661-E667.
    PubMed     Abstract available


  162. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    PubMed     Abstract available


  163. HERNANDEZ-ENRIQUEZ M, Belle L, Madiot H, Pansieri M, et al
    Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry.
    Catheter Cardiovasc Interv. 2021;98:874-881.
    PubMed     Abstract available


  164. MILEWSKI K, Bryla-Wojciechowska A, Buszman PP, Jelonek K, et al
    Nanospheres encapsulated everolimus delivery into arterial wall-the tissue pharmacokinetics and vascular response experimental study.
    Catheter Cardiovasc Interv. 2021;98:914-922.
    PubMed     Abstract available


  165. SALINAS P, Sanchez-Casanueva RM, Gonzalo N, A Gil J, et al
    Dose-reducing fluoroscopic system decreases patient but not occupational radiation exposure in chronic total occlusion intervention.
    Catheter Cardiovasc Interv. 2021;98:895-902.
    PubMed     Abstract available


  166. D'ASCENZO F, Saglietto A, Ramakrishna H, Andreis A, et al
    Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry.
    Catheter Cardiovasc Interv. 2021;98:864-871.
    PubMed     Abstract available


  167. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    PubMed     Abstract available


    October 2021
  168. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    PubMed     Abstract available


  169. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    PubMed     Abstract available


  170. HILLEGASS WB
    Diabetes and everolimus eluting bioresorbable poly-L-lactide vascular scaffolds for coronary artery disease: Dead-end or some path forward?
    Catheter Cardiovasc Interv. 2021;98:721-722.
    PubMed    


  171. LANTZ R, Henry TD
    STEMI in 90-year-olds: The good news and the bad news!
    Catheter Cardiovasc Interv. 2021;98:647-648.
    PubMed    


  172. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    PubMed     Abstract available


  173. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    PubMed     Abstract available


  174. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed     Abstract available


  175. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    PubMed     Abstract available


  176. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed     Abstract available


  177. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    PubMed     Abstract available


  178. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    PubMed     Abstract available


  179. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    PubMed     Abstract available


  180. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    PubMed     Abstract available


  181. KINI AS, Okamoto N, Barman N, Vengrenyuk Y, et al
    Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions: The ORBID-FFR study.
    Catheter Cardiovasc Interv. 2021;98:658-668.
    PubMed     Abstract available


  182. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed     Abstract available


  183. VETROVEC GW, Lim MJ, Needham KA
    Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: An episode-of-care analysis.
    Catheter Cardiovasc Interv. 2021;98:703-710.
    PubMed     Abstract available


  184. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    PubMed     Abstract available


    September 2021
  185. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    PubMed     Abstract available


  186. WATANABE Y, Mitomo S, Naganuma T, Chieffo A, et al
    The importance of proximal optimization technique with intravascular imaging guided for stenting unprotected left main distal bifurcation lesions: The Milan and New-Tokyo registry.
    Catheter Cardiovasc Interv. 2021 Sep 14. doi: 10.1002/ccd.29954.
    PubMed     Abstract available


  187. ULLAH W, Zghouzi M, Ahmad B, Suleiman AM, et al
    Safety and efficacy of the polymer-free and polymer-coated drug-eluting stents in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Sep 12. doi: 10.1002/ccd.29953.
    PubMed     Abstract available


  188. SHEIBAN I, Ge Z, Kan J, Nie S, et al
    Association of peri-procedural myocardial infarction with mortality after stenting true coronary bifurcation lesions: A pooled individual participant data analysis from four randomized controlled trials.
    Catheter Cardiovasc Interv. 2021 Sep 7. doi: 10.1002/ccd.29946.
    PubMed     Abstract available


  189. BEERKENS FJ, Singh R, Cao D, Claessen BE, et al
    Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
    Catheter Cardiovasc Interv. 2021 Sep 3. doi: 10.1002/ccd.29935.
    PubMed     Abstract available


  190. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    PubMed    


  191. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed    


  192. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed     Abstract available


  193. TZANIS G, Khokhar AA, Ponticelli F, Gallone G, et al
    Coronary sinus size and ischemia improvement after reducer implantation; "one size to fit them all?"
    Catheter Cardiovasc Interv. 2021;98:E365-E369.
    PubMed     Abstract available


  194. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed     Abstract available


  195. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    PubMed     Abstract available


  196. WU EB
    Rebuttal: Misconceptions in crossboss/stingray catheter use-Clarification from the hybrid group.
    Catheter Cardiovasc Interv. 2021;98:616.
    PubMed    


  197. PERSHAD A, Grantham JA, Thompson CA, Lombardi WL, et al
    Misconception in CrossBoss/stingray catheter use-clarification from the hybrid group.
    Catheter Cardiovasc Interv. 2021;98:615.
    PubMed    


  198. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    PubMed     Abstract available


  199. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    PubMed     Abstract available


  200. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    PubMed     Abstract available


  201. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed     Abstract available


  202. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed     Abstract available


  203. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed     Abstract available


  204. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    PubMed     Abstract available


  205. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    PubMed     Abstract available


    August 2021
  206. LICHAA H
    Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique.
    Catheter Cardiovasc Interv. 2021 Aug 31. doi: 10.1002/ccd.29940.
    PubMed     Abstract available


  207. MATSUOKA T, Kitahara H, Saito K, Mori N, et al
    Utility of near-infrared spectroscopy to detect the extent of lipid core plaque leading to periprocedural myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29927.
    PubMed     Abstract available


  208. CHANG CW, Wadia SK, Rastogi A, Stinis CT, et al
    A unique cause of coronary obstruction after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29919.
    PubMed     Abstract available


  209. YIN T, Zhong X, Tao L, Hu T, et al
    Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29931.
    PubMed     Abstract available


  210. ERDOGAN E, Huang X, Cooper J, Jain A, et al
    End-diastolic segmentation of intravascular ultrasound images enables more reproducible volumetric analysis of atheroma burden.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29917.
    PubMed     Abstract available


  211. BASIR MB, Lemor A, Gorgis S, Taylor AM, et al
    Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29895.
    PubMed     Abstract available


  212. JIA X, Jneid H
    Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned.
    Catheter Cardiovasc Interv. 2021;98:223-224.
    PubMed    


  213. WALDO SW, Plomondon ME, O'Donnell CI, Heidenreich PA, et al
    Trends in cardiovascular procedural volumes in the setting of COVID-19: Insights from the VA clinical assessment, reporting, and tracking program.
    Catheter Cardiovasc Interv. 2021;98:E326-E328.
    PubMed    


  214. GARCIA S, Stanberry L, Schmidt C, Sharkey S, et al
    Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
    Catheter Cardiovasc Interv. 2021;98:217-222.
    PubMed     Abstract available


  215. GRECO A, Spagnolo M, Capodanno D
    Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID-19 pandemic.
    Catheter Cardiovasc Interv. 2021;98:407-408.
    PubMed    


  216. TEHRANI DM, Seto AH
    Acute kidney injury in cardiogenic shock: The powerful distortions of survivor bias.
    Catheter Cardiovasc Interv. 2021;98:341-342.
    PubMed    


  217. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed     Abstract available


  218. LI C, Yang J, Dong S, Dong L, et al
    Multicenter clinical evaluation of a piezoresistive-MEMS-sensor rapid-exchange pressure microcatheter system for fractional flow reserve measurement.
    Catheter Cardiovasc Interv. 2021;98:E243-E253.
    PubMed     Abstract available


  219. PADKINS M, Breen T, Van Diepen S, Barsness G, et al
    Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021;98:330-340.
    PubMed     Abstract available


  220. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    PubMed     Abstract available


  221. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    PubMed     Abstract available


  222. MAATMAN B, Rios-Meza H, Guglin M, Revtyak G, et al
    A safe and simple method for axIABP placement using a left axillary-radial technique.
    Catheter Cardiovasc Interv. 2021;98:E310-E314.
    PubMed     Abstract available


  223. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed     Abstract available


  224. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    PubMed     Abstract available


  225. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    PubMed     Abstract available


  226. BODE WD, Bode MF
    Chronic total occlusion revascularization for ventricular arrhythmias?-Still more work to be done.
    Catheter Cardiovasc Interv. 2021;98:409.
    PubMed    


  227. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    PubMed    


  228. NAVARRO CASTELLANOS I, Dahdah N
    Letter to the Editor concerning the article: "Comparison of drug eluting versus bare metal stents".
    Catheter Cardiovasc Interv. 2021;98:E325.
    PubMed    


  229. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    PubMed     Abstract available


    July 2021
  230. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    PubMed     Abstract available


  231. SCHUMACHER SP, Everaars H, Stuijfzand WJ, van Diemen PA, et al
    Viability and functional recovery after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 30. doi: 10.1002/ccd.29888.
    PubMed     Abstract available


  232. MARCUSOHN E, Zukermann R, Kerner A, Roguin A, et al
    Long-term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29870.
    PubMed     Abstract available


  233. MEJIA-RENTERIA H, Lee JM, Choi KH, Lee SH, et al
    Coronary microcirculation assessment using functional angiography: Development of a wire-free method applicable to conventional coronary angiograms.
    Catheter Cardiovasc Interv. 2021 Jul 9. doi: 10.1002/ccd.29863.
    PubMed     Abstract available


  234. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 8. doi: 10.1002/ccd.29860.
    PubMed     Abstract available


  235. TAVENIER AH, Claassens DMF, Hermanides RS, Vos GJA, et al
    Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
    Catheter Cardiovasc Interv. 2021 Jul 7. doi: 10.1002/ccd.29861.
    PubMed     Abstract available


  236. SETO AH, Tehrani DM
    Intravascular ultrasound: Beneficial even with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021;98:10-11.
    PubMed    


  237. DANGAS GD, Tomey MI
    Shock indices in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021;98:95-96.
    PubMed    


  238. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    PubMed    


  239. VETROVEC GW
    Preventing NSTEMI readmissions: Starting from the beginning.
    Catheter Cardiovasc Interv. 2021;98:22-23.
    PubMed    


  240. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    PubMed     Abstract available


  241. TAHIR H, Tonks R, Cox J, Baljepally R, et al
    Optimizing mechanical circulatory support hemodynamics using coronary sinus pacing.
    Catheter Cardiovasc Interv. 2021;98:E78-E84.
    PubMed     Abstract available


  242. DAHAL S, Budoff MJ
    Anatomic burden mostly outperforms ischemic burden: From COURAGE to ISCHEMIA.
    Catheter Cardiovasc Interv. 2021;98:E106-E107.
    PubMed    


  243. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed     Abstract available


  244. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    PubMed     Abstract available


  245. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed     Abstract available


  246. VERHEYE S, Wlodarczak A, Montorsi P, Torzewski J, et al
    BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.
    Catheter Cardiovasc Interv. 2021;98:E1-E8.
    PubMed     Abstract available


  247. SHEIKH O, Nguyen T, Bansal S, Prasad A, et al
    Acute kidney injury in cardiogenic shock: A comprehensive review.
    Catheter Cardiovasc Interv. 2021;98:E91-E105.
    PubMed     Abstract available


  248. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    PubMed     Abstract available


  249. BRIGUORI C, Golino M, Porchetta N, Scarpelli M, et al
    Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;98:76-84.
    PubMed     Abstract available


  250. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed     Abstract available


  251. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed     Abstract available


  252. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    PubMed     Abstract available


  253. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed     Abstract available


    June 2021
  254. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed     Abstract available


  255. KIM Y, Shapero K, Ahn SS, Goldsweig AM, et al
    Outcomes of mechanical circulatory support for acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Jun 22. doi: 10.1002/ccd.29834.
    PubMed     Abstract available


  256. GRINES CL, Leach C
    Acute myocardial infarction related cardiogenic shock: How important is vascular access site?
    Catheter Cardiovasc Interv. 2021;97:1367-1368.
    PubMed    


  257. KERN MJ, Seto AH
    Post-dilation in ST-elevation MI patients makes sense anatomically, but does it improve physiology?
    Catheter Cardiovasc Interv. 2021;97:1318-1319.
    PubMed    


  258. BELARDI JA, Lamelas PM
    Contemporary stents: Tough to get better.
    Catheter Cardiovasc Interv. 2021;97:1352-1353.
    PubMed    


  259. NAGARAJA V, Rao SV, George S, Mamas M, et al
    Evidence-based arterial access site practice in patients with acute coronary syndromes: Has SAFARI-STEMI changed the landscape?
    Catheter Cardiovasc Interv. 2021;97:1417-1421.
    PubMed    


  260. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    PubMed     Abstract available


  261. WILGENHOF A, Zivelonghi C, Verheye S, Vermeersch P, et al
    Coronary sinus anatomical features: Description and procedural implications during coronary sinus Reducer implantation.
    Catheter Cardiovasc Interv. 2021;97:E929-E935.
    PubMed     Abstract available


  262. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Brilakis ES, et al
    Combined use of intravascular lithotripsy and brachytherapy: A new approach for the treatment of recurrent coronary in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97:1402-1406.
    PubMed     Abstract available


  263. ANDO G, Capodanno D
    Safe femoral access for STEMI patients and mortality in the new decade: Back to the future?
    Catheter Cardiovasc Interv. 2021;97:E1054-E1056.
    PubMed    


  264. PATEL NJ, Okamoto N, Murphy J, Vengrenyuk Y, et al
    Management of calcified coronary artery bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:1407-1416.
    PubMed     Abstract available


  265. TEHRANI BN, Damluji AA, Sherwood MW, Rosner C, et al
    Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.
    Catheter Cardiovasc Interv. 2021;97:1354-1366.
    PubMed     Abstract available


  266. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    PubMed     Abstract available


  267. LI X, Kan J, She L, Shrestha R, et al
    Optical coherence tomography predictors of target vessel myocardial infarction after provisional stenting in patients with coronary bifurcation disease.
    Catheter Cardiovasc Interv. 2021;97:1331-1340.
    PubMed     Abstract available


  268. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;97:1341-1351.
    PubMed     Abstract available


  269. KURIHARA O, Shinohara H, Kim HO, Russo M, et al
    Comparison of post-stent optical coherence tomography findings: Layered versus non-layered culprit lesions.
    Catheter Cardiovasc Interv. 2021;97:1320-1328.
    PubMed     Abstract available


  270. KARAMASIS GV, Kalogeropoulos AS, Gamma RA, Clesham GJ, et al
    Effects of stent postdilatation during primary PCI for STEMI: Insights from coronary physiology and optical coherence tomography.
    Catheter Cardiovasc Interv. 2021;97:1309-1317.
    PubMed     Abstract available


  271. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    PubMed     Abstract available


    May 2021
  272. LEE KH, Torii S, Oguri M, Miyaji T, et al
    Reduction of door-to-balloon time in patients with ST-elevation myocardial infarction by single-catheter primary percutaneous coronary intervention method.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29797.
    PubMed     Abstract available


  273. COSGROVE C, Hanratty CG, Hill JM, Mahadevan K, et al
    Intravascular lithotripsy for treatment of calcific coronary lesions in ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29801.
    PubMed     Abstract available


  274. JENTZER JC, van Diepen S, Henry TD, Baran DA, et al
    Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021 May 28. doi: 10.1002/ccd.29800.
    PubMed     Abstract available


  275. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed     Abstract available


  276. BALDI C, Silverio A, Esposito L, Di Maio M, et al
    Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia.
    Catheter Cardiovasc Interv. 2021 May 5. doi: 10.1002/ccd.29738.
    PubMed     Abstract available


  277. SHOAIB A, Mohamed M, Curzen N, Ludman P, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29691.
    PubMed     Abstract available


  278. AHMAD K, Abbott JD
    Supersaturated oxygen therapy in acute anterior myocardial infarction: Going small is the next big thing.
    Catheter Cardiovasc Interv. 2021;97:1127-1128.
    PubMed    


  279. TARANTINI G, Fraccaro C
    Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:1268-1269.
    PubMed    


  280. SHAH J, Levy MS
    GRACEfully assessing the timeline for noninfarct-related artery intervention in ST-elevation myocardial infarction patients.
    Catheter Cardiovasc Interv. 2021;97:1160-1161.
    PubMed    


  281. TOPAZ O
    The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI.
    Catheter Cardiovasc Interv. 2021;97:1149-1150.
    PubMed    


  282. GUDDETI RR, Brilakis ES
    With great power comes great responsibility: When and how to use the retrograde approach to chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2021;97:1174-1175.
    PubMed    


  283. SHADMAN S, Heyliger S, Watts C, Aghili N, et al
    Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives.
    Catheter Cardiovasc Interv. 2021;97:1296-1300.
    PubMed     Abstract available


  284. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    PubMed     Abstract available


  285. LEMOR A, Al-Darzi W, O'Neill W, Basir MB, et al
    Unmasking right ventricular failure in cardiogenic shock: The importance of serial hemodynamics.
    Catheter Cardiovasc Interv. 2021;97:1209-1212.
    PubMed     Abstract available


  286. ALLAHWALA UK, Nour D, Bhatia K, Ward MR, et al
    Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients.
    Catheter Cardiovasc Interv. 2021;97:E771-E777.
    PubMed     Abstract available


  287. MEDRANDA GA, Lance S, Waksman R, Bernardo NL, et al
    Colossal left main to right atrium fistula ligation complicated by left circumflex STEMI.
    Catheter Cardiovasc Interv. 2021;97:1218-1220.
    PubMed     Abstract available


  288. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:1162-1173.
    PubMed     Abstract available


  289. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    PubMed     Abstract available


  290. WERNER GS, Yaginuma K, Koch M, Tischer K, et al
    Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention.
    Catheter Cardiovasc Interv. 2021;97:1196-1206.
    PubMed     Abstract available


  291. CHEN S, David SW, Khan ZA, Metzger DC, et al
    One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2021;97:1120-1126.
    PubMed     Abstract available


  292. VOGT JC, Manning PG, Sheikh O, Aronow HD, et al
    The role of rivaroxaban for patients with atherosclerotic vascular disease in the modern era.
    Catheter Cardiovasc Interv. 2021;97:1221-1229.
    PubMed    


  293. KIM MC, Bae S, Ahn Y, Sim DS, et al
    Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Catheter Cardiovasc Interv. 2021;97:1151-1159.
    PubMed     Abstract available


  294. PAHUJA M, Ranka S, Chehab O, Mishra T, et al
    Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:1129-1138.
    PubMed     Abstract available


  295. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2021;97:1186-1193.
    PubMed     Abstract available


  296. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
    Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
    Catheter Cardiovasc Interv. 2021;97:1109-1117.
    PubMed     Abstract available


  297. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2021;97:1176-1183.
    PubMed     Abstract available


  298. MEIER D, Fournier S, Masci PG, Eeckhout E, et al
    Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
    Catheter Cardiovasc Interv. 2021;97:1141-1148.
    PubMed     Abstract available


  299. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed     Abstract available


  300. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed     Abstract available


  301. REN Y, Li X, Wang S, Pan W, et al
    Serum alkaline phosphatase levels are associated with coronary artery calcification patterns and plaque vulnerability.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1055-1062.
    PubMed     Abstract available


  302. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    PubMed     Abstract available


    April 2021
  303. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed     Abstract available


  304. PAGNONI M, Meier D, Candreva A, Maillard L, et al
    Future culprit detection based on angiography-derived FFR.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29736.
    PubMed     Abstract available


  305. ABIZAID A, Campos CM, Guimaraes PO, Costa JR Jr, et al
    Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.
    Catheter Cardiovasc Interv. 2021 Apr 27. doi: 10.1002/ccd.29709.
    PubMed     Abstract available


  306. TYLER JM, Brown C, Jentzer JC, Baran DA, et al
    Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials.
    Catheter Cardiovasc Interv. 2021 Apr 19. doi: 10.1002/ccd.29710.
    PubMed     Abstract available


  307. XU M, Demuyakor A, Hu S, Liu H, et al
    Is the effect of atorvastatin 60 mg on stabilization of lipid-rich plaque equivalent to that of rosuvastatin 10 mg? A serial optical coherence tomography combined with intravascular ultrasound imaging.
    Catheter Cardiovasc Interv. 2021 Apr 17. doi: 10.1002/ccd.29654.
    PubMed     Abstract available


  308. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    PubMed     Abstract available


  309. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    PubMed     Abstract available


  310. NAKAMURA S, Yonetsu T, Hoshino M, Hada M, et al
    Anatomical-functional discordance between quantitative coronary angiography and diastolic pressure ratio during wave-free period.
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29680.
    PubMed     Abstract available


  311. SHARMA SK, Fuster V, Hofstra L, Kini AS, et al
    Lessons learned from reduced acute cardiovascular events and STEMI during Covid-19.
    Catheter Cardiovasc Interv. 2021;97:850-852.
    PubMed    


  312. RIVERO F, Antuna P, Cuesta J, Alfonso F, et al
    Severe coronary spasm in a COVID-19 patient.
    Catheter Cardiovasc Interv. 2021;97:E670-E672.
    PubMed     Abstract available


  313. LOPEZ JJ, Ebinger JE, Allen S, Yildiz M, et al
    Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge.
    Catheter Cardiovasc Interv. 2021;97:847-849.
    PubMed     Abstract available


  314. EID-LIDT G, Farjat Pasos JI
    Patient care protocols and personal safety measures for health care professionals in cardiac catheterization rooms during the COVID-19 outbreak in the National Institute of Cardiology.
    Catheter Cardiovasc Interv. 2021;97:E686-E691.
    PubMed     Abstract available


  315. SETO AH, Kern MJ
    QFR accuracy and Pd/pa:FFR discordance: Too much inside baseball or novel physiologic insight?
    Catheter Cardiovasc Interv. 2021;97:833-835.
    PubMed    


  316. ASHLEY KE, Hillegass WB
    Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Catheter Cardiovasc Interv. 2021;97:795-796.
    PubMed    


  317. OSMAN M, Syed M, Abdul Ghaffar Y, Patel B, et al
    Gender-based outcomes of impeller pumps percutaneous ventricular assist devices.
    Catheter Cardiovasc Interv. 2021;97:E627-E635.
    PubMed     Abstract available


  318. LEE CH, Ahn JM, Kang DY, Han M, et al
    Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:776-785.
    PubMed     Abstract available


  319. SHAIK A, Mosleh W, Dahal K, Pickett C, et al
    The absence of evidence is not the evidence of absence: A case report on the challenges in diagnosing ostial left main stenosis.
    Catheter Cardiovasc Interv. 2021;97:836-840.
    PubMed     Abstract available


  320. KITANI S, Igarashi Y, Tsuchikane E, Nakamura S, et al
    Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry).
    Catheter Cardiovasc Interv. 2021;97:E614-E623.
    PubMed     Abstract available


  321. FABBIOCCHI F, Calligaris G, Bartorelli AL
    Progressive growth of coronary aneurysms after bioresorbable vascular scaffold implantation: Successful treatment with OCT-guided exclusion using covered stents.
    Catheter Cardiovasc Interv. 2021;97:E676-E679.
    PubMed     Abstract available


  322. WESTRA J, Eftekhari A, Tu S, Campo G, et al
    Resting distal to aortic pressure ratio and fractional flow reserve discordance affects the diagnostic performance of quantitative flow ratio: Results from an individual patient data meta-analysis.
    Catheter Cardiovasc Interv. 2021;97:825-832.
    PubMed     Abstract available


  323. ALSAAD AA, Russell HM, Tokarczyk AJ, Ricciardi MJ, et al
    Hybrid approach to postmyocardial infarction ventricular septal defect repair.
    Catheter Cardiovasc Interv. 2021;97:E731-E735.
    PubMed     Abstract available


  324. NAZIR S, Ahuja KR, Virk HUH, Elzanaty A, et al
    A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:788-794.
    PubMed     Abstract available


  325. CORTES C, Carrasco-Moraleja M, Aparisi A, Rodriguez-Gabella T, et al
    Quantitative flow ratio-Meta-analysis and systematic review.
    Catheter Cardiovasc Interv. 2021;97:807-814.
    PubMed     Abstract available


  326. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed     Abstract available


    March 2021
  327. ZHAO L, Du Z, Wu T, Cao M, et al
    Association of the age shock index with coronary plaque characteristics in ST-segment elevation myocardial infarction: A 3-vessel optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021 Mar 29. doi: 10.1002/ccd.29652.
    PubMed     Abstract available


  328. LIU ZY, Yin ZH, Liang CY, He J, et al
    Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29655.
    PubMed     Abstract available


  329. MOHAMED MO, Curzen N, de Belder M, Goodwin AT, et al
    Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29663.
    PubMed     Abstract available


  330. HU X, Qiao S, Guan C, Guo C, et al
    Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29651.
    PubMed     Abstract available


  331. PLOUMEN EH, Buiten RA, Zocca P, Doggen CJM, et al
    Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29594.
    PubMed     Abstract available


  332. BASIR MB, Pinto DS, Ziaeian B, Khandelwal A, et al
    Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials.
    Catheter Cardiovasc Interv. 2021 Mar 7. doi: 10.1002/ccd.29593.
    PubMed     Abstract available


  333. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed     Abstract available


  334. TU S, Ding D, Chang Y, Li C, et al
    Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: A novel method based on bifurcation fractal law.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29592.
    PubMed     Abstract available


  335. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed     Abstract available


  336. LIU S, Song C, Yin D, Wang Y, et al
    Impact of public health emergency response to COVID-19 on management and outcome for NSTEMI patients in Beijing: A single-center historic control.
    Catheter Cardiovasc Interv. 2021;97:E475-E483.
    PubMed     Abstract available


  337. SMALLING RW
    Pre-transfer/PCI with ticagrelor and heparin administration in STEMI patients may be beneficial but should we do more?
    Catheter Cardiovasc Interv. 2021;97:600-601.
    PubMed    


  338. AGARWAL SK, Uretsky BF
    Is it time for a "functional" hybrid algorithm to optimize interventional results in chronic total occlusion?
    Catheter Cardiovasc Interv. 2021;97:656-657.
    PubMed    


  339. PATEL NJ, Heuser RR
    "PROGRESS is our most important product": Adventures in CTO intervention.
    Catheter Cardiovasc Interv. 2021;97:668-669.
    PubMed    


  340. TOMANIAK M, Masdjedi K, van Zandvoort LJ, Neleman T, et al
    Correlation between 3D-QCA based FFR and quantitative lumen assessment by IVUS for left main coronary artery stenoses.
    Catheter Cardiovasc Interv. 2021;97:E495-E501.
    PubMed     Abstract available


  341. JOSHI FR, Lonborg J, Sadjadieh G, Helqvist S, et al
    The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: Results from the DANAMI-3-PRIMULTI randomized study.
    Catheter Cardiovasc Interv. 2021;97:E467-E474.
    PubMed     Abstract available


  342. NAVARESE EP, Frediani L, Kandzari DE, Caiazzo G, et al
    Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.
    Catheter Cardiovasc Interv. 2021;97:602-611.
    PubMed     Abstract available


  343. LEE SH, Choi KH, Lee JM, Shin D, et al
    Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization.
    Catheter Cardiovasc Interv. 2021;97:E454-E466.
    PubMed     Abstract available


  344. KAYAERT P, Coeman M, Drieghe B, Bennett J, et al
    iFR uncovers profound but mostly reversible ischemia in CTOs and helps to optimize PCI results.
    Catheter Cardiovasc Interv. 2021;97:646-655.
    PubMed     Abstract available


  345. NAKAJIMA A, Araki M, Kurihara O, Minami Y, et al
    Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:634-645.
    PubMed     Abstract available


    February 2021
  346. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    PubMed     Abstract available


  347. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    PubMed     Abstract available


  348. ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
    Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
    PubMed     Abstract available


  349. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    PubMed     Abstract available


  350. CASTAGNA F, Cerrud-Rodriguez R, Villela MA, Bortnick AE, et al
    SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:E339-E342.
    PubMed     Abstract available


  351. ROTHSTEIN ES, Welch TD, Andrus BW, Jayne JE, et al
    Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.
    Catheter Cardiovasc Interv. 2021;97:E333-E338.
    PubMed     Abstract available


  352. BORTNICK AE
    COVID-19: The personal and professional impact of one case.
    Catheter Cardiovasc Interv. 2021;97:E352-E353.
    PubMed    


  353. RAZZOUK L, Jneid H
    Revascularization in patients with diabetes and chronic total occlusion: The journey or the destination?
    Catheter Cardiovasc Interv. 2021;97:384-385.
    PubMed    


  354. AFANA M, Altawil M, Basir M, Alqarqaz M, et al
    Transcaval access for the emergency delivery of 5.0 liters per minute mechanical circulatory support in cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:555-564.
    PubMed     Abstract available


  355. KUMAR A, Sammour Y, Reginauld S, Sato K, et al
    Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv. 2021;97:529-539.
    PubMed     Abstract available


  356. CHIABRANDO JG, Lombardi M, Vescovo GM, Wohlford GF, et al
    Stenting techniques for coronary bifurcation lesions: Evidence from a network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2021;97:E306-E318.
    PubMed     Abstract available


  357. MADDER RD, VanOosterhout S, Parker J, Sconzert K, et al
    Robotic telestenting performance in transcontinental and regional pre-clinical models.
    Catheter Cardiovasc Interv. 2021;97:E327-E332.
    PubMed     Abstract available


  358. YASUMURA K, Benhuri B, Vengrenyuk Y, Petrov A, et al
    Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.
    Catheter Cardiovasc Interv. 2021;97:E280-E287.
    PubMed     Abstract available


  359. KIM HO, Kim CJ, Cho JM, Soeda T, et al
    Characteristics of non-culprit plaques in acute coronary syndrome patients with calcified plaque at the culprit lesion.
    Catheter Cardiovasc Interv. 2021;97:E298-E305.
    PubMed     Abstract available


  360. PAREEK N, Dworakowski R, Webb I, Barash J, et al
    SCAI cardiogenic shock classification after out of hospital cardiac arrest and association with outcome.
    Catheter Cardiovasc Interv. 2021;97:E288-E297.
    PubMed     Abstract available


  361. OSHEROV AB, Qiang B, Butany J, Wright GA, et al
    A calcified chronic total occlusion preclinical model.
    Catheter Cardiovasc Interv. 2021;97:437-442.
    PubMed     Abstract available


  362. FLORES-UMANZOR EJ, Cepas-Guillen PL, Vazquez S, Fernandez-Valledor A, et al
    Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes.
    Catheter Cardiovasc Interv. 2021;97:376-383.
    PubMed     Abstract available


  363. SAITO Y, Cristea E, Bouras G, Abizaid A, et al
    Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffold.
    Catheter Cardiovasc Interv. 2021;97:431-436.
    PubMed     Abstract available


  364. GONG Y, Zheng B, Yi T, Yang F, et al
    Coronary angiography-derived contrast fractional flow reserve.
    Catheter Cardiovasc Interv. 2021 Feb 15. doi: 10.1002/ccd.29558.
    PubMed     Abstract available


  365. YA'QOUB L, Gad M, Saad AM, Elgendy IY, et al
    National trends of utilization and readmission rates with intravascular ultrasound use for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29524.
    PubMed     Abstract available


  366. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    PubMed     Abstract available


  367. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.
    PubMed    


  368. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed     Abstract available


  369. SHIELDS MC, Ouellette M, Kiefer N, Kohan L, et al
    Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29508.
    PubMed     Abstract available


  370. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    PubMed     Abstract available


  371. PICCOLO R, Esposito G
    Percutaneous coronary intervention in patients with COVID-19 and acute coronary syndrome: What if the old normal became the new normal?
    Catheter Cardiovasc Interv. 2021;97:199-200.
    PubMed    


  372. GOLAMARI RR, Gilchrist IC
    STEMI and COVID-19: Unmasking failures and opportunities to enhance future care.
    Catheter Cardiovasc Interv. 2021;97:215-216.
    PubMed    


  373. GRINES CL
    SCAI consumer survey comparing fear of COVID-19 versus heart attack or stroke (first publish date: September 4, 2020).
    Catheter Cardiovasc Interv. 2021;97:193-194.
    PubMed    


  374. SECCO GG, Tarantini G, Mazzarotto P, Garbo R, et al
    Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience.
    Catheter Cardiovasc Interv. 2021;97:195-198.
    PubMed     Abstract available


  375. KAYANI WT, Jneid H
    Increasing stroke events in patients with ST elevation myocardial infraction and cardiogenic shock: A cause for concern.
    Catheter Cardiovasc Interv. 2021;97:226-227.
    PubMed     Abstract available


  376. BUTMAN SM
    Hybrid revascularization procedures for multivessel disease: 2021.
    Catheter Cardiovasc Interv. 2021;97:265-266.
    PubMed    


  377. BARRETT C, Warsavage T, Kovach C, McGuinn E, et al
    Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program.
    Catheter Cardiovasc Interv. 2021;97:E219-E226.
    PubMed     Abstract available


  378. GALLONE G, D'Ascenzo F, Conrotto F, Costa F, et al
    Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations.
    Catheter Cardiovasc Interv. 2021;97:E227-E236.
    PubMed     Abstract available


  379. YAMANAGA K, Sakamoto K, Kajiwara I, Tsujita K, et al
    Coronary artery perforation into the upper gastrointestinal cavity due to gastric ulceration.
    Catheter Cardiovasc Interv. 2021;97:E237-E240.
    PubMed     Abstract available


  380. TAMARU H, Fujii K, Otsuji S, Takiuchi S, et al
    Short- and mid-term influence of drug-coated stent implantation on structural and functional vascular healing response: An optical coherence tomography and acetylcholine testing study.
    Catheter Cardiovasc Interv. 2021;97:E186-E193.
    PubMed     Abstract available


  381. WATANABE Y, Mitomo S, Naganuma T, Kawamoto H, et al
    Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2021;97:E198-E208.
    PubMed     Abstract available


  382. HUSSAIN HI, Protty MB, Gallagher S, Al-Raisi S, et al
    The impact of coronary perforation in percutaneous interventions involving the left main stem coronary artery in the United Kingdom 2007-2014: Insights from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E179-E185.
    PubMed     Abstract available


  383. WEERTS J, Pustjens T, Amin E, Ilhan M, et al
    Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:247-256.
    PubMed     Abstract available


  384. PAHUJA M, Chehab O, Ranka S, Mishra T, et al
    Incidence and clinical outcomes of stroke in ST-elevation myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:217-225.
    PubMed     Abstract available


    January 2021
  385. SU X, Yang W, Zhu Z, Zhang R, et al
    Heartech(R) left ventricular partitioning device improves left ventricular systolic function of patients with chronic heart failure post-myocardial infarction at 1-year follow-up.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29489.
    PubMed     Abstract available


  386. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    PubMed     Abstract available


  387. MCKENZIE A, Zhou C, Svendsen C, Anketell R, et al
    Ability of a novel shock index that incorporates invasive hemodynamics to predict mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Jan 9. doi: 10.1002/ccd.29460.
    PubMed     Abstract available


  388. KRAJCER Z, Costello B
    Clinical impact of calcified nodules in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:20-21.
    PubMed     Abstract available


  389. RODRIGUEZ-PAZ E, Heuser R
    "Back to the future: Beta radiation to treat recurrent in-stent restenosis".
    Catheter Cardiovasc Interv. 2021;97:47.
    PubMed     Abstract available


  390. BALTER S, Moses JW
    Intravascular brachytherapy is a good clinical option for refractory in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97:39-40.
    PubMed    


  391. SMITH T, Henry TD
    Spontaneous coronary artery dissection with cardiogenic shock: How frequent is it? How should we treat it?
    Catheter Cardiovasc Interv. 2021;97:78-79.
    PubMed     Abstract available


  392. GRINES CL, Yen A
    Between a rock and a hard place: Orbital atherectomy for under-expanded stents.
    Catheter Cardiovasc Interv. 2021;97:8-9.
    PubMed     Abstract available


  393. KERN MJ
    Is stealing still a crime? Comment on left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021;97:105-107.
    PubMed     Abstract available


  394. FAN LM, Tong D, Mintz GS, Mamas MA, et al
    Breaking the deadlock of calcified coronary artery lesions: A contemporary review.
    Catheter Cardiovasc Interv. 2021;97:108-120.
    PubMed     Abstract available


  395. LUDWIG J, Mohamed M, Mamas MA
    Left main bifurcation lesions: Medina reclassification revisited-as easy as ABC.
    Catheter Cardiovasc Interv. 2021;97:186-187.
    PubMed    


  396. SHEKILADZE N, Condado JF, Sandesara PB, Kim JH, et al
    A single healthcare experience with Impella RP.
    Catheter Cardiovasc Interv. 2021;97:E161-E167.
    PubMed     Abstract available


  397. DI MARCO A, Anguera I, Nombela-Franco L, Oloriz T, et al
    Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Catheter Cardiovasc Interv. 2021;97:E1-E11.
    PubMed     Abstract available


  398. MCQUILLAN C, Jackson MWP, Brilakis ES, Egred M, et al
    Uncrossable and undilatable lesions-A practical approach to optimizing outcomes in PCI.
    Catheter Cardiovasc Interv. 2021;97:121-126.
    PubMed     Abstract available


  399. AZZALINI L, Alaswad K, Uretsky BF, Agostoni P, et al
    Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2021;97:E40-E50.
    PubMed     Abstract available


  400. LAMELAS P, Padilla L, Abud M, Cigalini I, et al
    In-stent chronic total occlusion angioplasty in the LATAM-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:E34-E39.
    PubMed     Abstract available


  401. MOROFUJI T, Kuramitsu S, Shinozaki T, Jinnouchi H, et al
    Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:10-19.
    PubMed     Abstract available


  402. WIEBE J, Hofmann FJ, Dorr O, Bauer T, et al
    Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.
    Catheter Cardiovasc Interv. 2021;97:56-62.
    PubMed     Abstract available


  403. NEUPANE S, Basir M, Tan C, Sultan A, et al
    Feasibility and safety of orbital atherectomy for the treatment of in-stent restenosis secondary to stent under-expansion.
    Catheter Cardiovasc Interv. 2021;97:2-7.
    PubMed     Abstract available


  404. MEGALY M, Glogoza M, Xenogiannis I, Vemmou E, et al
    Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97:32-38.
    PubMed     Abstract available


  405. MERAJ PM, Patel K, Patel A, Doshi R, et al
    Northwell intracoronary brachytherapy for the treatment of recurrent drug eluting stent in-stent restenosis (NITDI study group).
    Catheter Cardiovasc Interv. 2021;97:41-46.
    PubMed     Abstract available


  406. YEOH J, Cottens D, Cosgrove C, Mallek K, et al
    Management of stent underexpansion using intravascular lithotripsy-Defining the utility of a novel device.
    Catheter Cardiovasc Interv. 2021;97:22-29.
    PubMed     Abstract available


  407. SHARMA S, Polak S, George Z, LeDoux J, et al
    Management of spontaneous coronary artery dissection complicated by cardiogenic shock using mechanical circulatory support with the Impella device.
    Catheter Cardiovasc Interv. 2021;97:74-77.
    PubMed     Abstract available


    December 2020
  408. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    PubMed     Abstract available


  409. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed     Abstract available


  410. ABIZAID A, Kedev S, Ali RBM, Santoso T, et al
    Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29396.
    PubMed     Abstract available


    November 2020
  411. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    PubMed     Abstract available


  412. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    PubMed     Abstract available


  413. TEBALDI M, Biscaglia S, Erriquez A, Penzo C, et al
    Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29380.
    PubMed     Abstract available


  414. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    PubMed     Abstract available


  415. SUGIYAMA T, Kanno Y, Hamaya R, Kanaji Y, et al
    Determinants of visual-functional mismatches as assessed by coronary angiography and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2020 Nov 16. doi: 10.1002/ccd.29388.
    PubMed     Abstract available


  416. KAWASHIMA H, Hara H, Wang R, Ono M, et al
    Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29383.
    PubMed     Abstract available


  417. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  418. POSTALIAN A, Krajcer Z
    Chronic total occlusion percutaneous coronary intervention: The Latin American experience.
    Catheter Cardiovasc Interv. 2020;96:1056-1057.
    PubMed    


    October 2020
  419. JONES TL, Golomb M, Dranow E, Welt FGP, et al
    The case for a qualitative lesion assessment system for coronary angiography.
    Catheter Cardiovasc Interv. 2020 Oct 31. doi: 10.1002/ccd.29334.
    PubMed     Abstract available


  420. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed     Abstract available


  421. ALRAIES MC, Al-Khadra Y
    Heterogeneity of Impella use in the United States for high-risk coronary interventions.
    Catheter Cardiovasc Interv. 2020 Oct 24. doi: 10.1002/ccd.29346.
    PubMed    


  422. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    PubMed     Abstract available


  423. GOEL R, Cao D, Chandiramani R, Roumeliotis A, et al
    Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29314.
    PubMed     Abstract available


  424. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    PubMed     Abstract available


  425. PAJJURU VS, Thandra A, Guddeti RR, Kothapalli SR, et al
    ST-elevation myocardial infarction in nonagenarians: A nationwide analysis of trends and outcomes in the United States.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29313.
    PubMed     Abstract available


  426. KERN MJ, Seto AH
    Comparing QFR and FFR in small vessels-Expanding the spectrum of use.
    Catheter Cardiovasc Interv. 2020;96:752-754.
    PubMed    


  427. COLOMBO A, Laricchia A
    Removing the plaque and implanting a drug-eluting stent: The way to success.
    Catheter Cardiovasc Interv. 2020;96:782-783.
    PubMed    


  428. RODRIGUEZ-PAZ E, Heuser RR
    Sometimes you just don't know: Adventures in octopus trapping.
    Catheter Cardiovasc Interv. 2020;96:830.
    PubMed    


  429. GIANNINI F, Tzanis G, Banai S, Colombo A, et al
    Incomplete coronary sinus reducer endothelialization as potential mechanism of clinical failure.
    Catheter Cardiovasc Interv. 2020;96:E493-E494.
    PubMed    


  430. ZIVELONGHI C, Vermeersch G, Verheye S, Agostoni P, et al
    Reply to the letter regarding: "Incomplete coronary sinus reducer endothelialisation as potential mechanism of clinical failure".
    Catheter Cardiovasc Interv. 2020;96:E495.
    PubMed    


    September 2020
  431. PIRIOU PG, Bonin M, Huchet F, Letocart V, et al
    Standardized fractal bench test evaluation of coronary stents: Performances in bifurcation lesions treated by the re-proximal optimization technique.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29288.
    PubMed     Abstract available


  432. KUNO T, Takagi H, Ando T, Kodaira M, et al
    Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29236.
    PubMed     Abstract available


  433. MAHMUD E
    The Evolving Pandemic of COVID-19 and Interventional Cardiology.
    Catheter Cardiovasc Interv. 2020;96:507-508.
    PubMed    


  434. SCHAMROTH PRAVDA N, Kornowski R
    Treating cardiogenic shock and cardiac arrest: The right place, the right time, the right equipment.
    Catheter Cardiovasc Interv. 2020;96:556-557.
    PubMed     Abstract available


  435. MUSUMECI G, Annibali G
    Upstream anticoagulation: Another brick in the wall?
    Catheter Cardiovasc Interv. 2020;96:526-527.
    PubMed    


  436. KERN MJ, Seto AH
    Collaterals in STEMI patients: An uncommon but critical lifeline.
    Catheter Cardiovasc Interv. 2020;96:534-535.
    PubMed     Abstract available


  437. RODRIGUEZ-PAZ E, Heuser RR
    A new perspective in CTO PCI.
    Catheter Cardiovasc Interv. 2020;96:577.
    PubMed    


  438. SHARKEY SW, Henry TD, Maron BJ
    Response: How common is comorbid takotsubo syndrome in patients with acute coronary syndromes?
    Catheter Cardiovasc Interv. 2020;96:727.
    PubMed    


  439. MADIAS JE
    How common is comorbid takotsubo syndrome in patients with acute coronary syndromes?
    Catheter Cardiovasc Interv. 2020;96:725-726.
    PubMed    


  440. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  441. ARANZULLA TC
    One, two, three ... breakdance and twist.
    Catheter Cardiovasc Interv. 2020;96:601-608.
    PubMed     Abstract available


  442. TOVAR FORERO MN, Van Mieghem NM, Daemen J
    Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
    Catheter Cardiovasc Interv. 2020;96:598-600.
    PubMed     Abstract available


  443. ABU SHARAR H, Helfert S, Vafaie M, Pleger ST, et al
    Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Catheter Cardiovasc Interv. 2020;96:578-585.
    PubMed     Abstract available


  444. KANDZARI DE, Lembo NJ, Carlson HD, Kalynych A, et al
    Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study.
    Catheter Cardiovasc Interv. 2020;96:567-576.
    PubMed     Abstract available


  445. PARR CJ, Sharma R, Arora RC, Singal R, et al
    Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory.
    Catheter Cardiovasc Interv. 2020;96:547-555.
    PubMed     Abstract available


  446. DE ROECK F, Tijskens M, Segers VFM
    Coronary-subclavian steal syndrome, an easily overlooked entity in interventional cardiology.
    Catheter Cardiovasc Interv. 2020;96:614-619.
    PubMed     Abstract available


  447. JOHNSON DT, Fournier S, Kirkeeide RL, De Bruyne B, et al
    Phasic pressure measurements for coronary and valvular interventions using fluid-filled catheters: Errors, automated correction, and clinical implications.
    Catheter Cardiovasc Interv. 2020;96:E268-E277.
    PubMed     Abstract available


  448. NOAMAN S, Andrianopoulos N, Brennan AL, Dinh D, et al
    Outcomes of cardiogenic shock complicating acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020;96:E257-E267.
    PubMed     Abstract available


  449. GALLONE G, D'Ascenzo F, Boccuzzi G, Cortese B, et al
    Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
    Catheter Cardiovasc Interv. 2020;96:E248-E256.
    PubMed     Abstract available


  450. KANNO Y, Sugiyama T, Hoshino M, Usui E, et al
    Optical coherence tomography-defined plaque vulnerability in relation to functional stenosis severity stratified by fractional flow reserve and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2020;96:E238-E247.
    PubMed     Abstract available


  451. KOREN O, Abu Rajab Saaida R, Rozner E, Turgeman Y, et al
    Outcomes and safety of concurrent coronary and peripheral catheterization (REVascularization in concomitant PERIpheral artery disease and coronary artery disease REV-PERICAD Study).
    Catheter Cardiovasc Interv. 2020;96:E317-E323.
    PubMed     Abstract available


  452. SONCK J, Collet C, Mizukami T, Vandeloo B, et al
    Motorized fractional flow reserve pullback: Accuracy and reproducibility.
    Catheter Cardiovasc Interv. 2020;96:E230-E237.
    PubMed     Abstract available


  453. SCHRAGE B, Dabboura S, Yan I, Hilal R, et al
    Application of the SCAI classification in a cohort of patients with cardiogenic shock.
    Catheter Cardiovasc Interv. 2020;96:E213-E219.
    PubMed     Abstract available


  454. HASEGAWA K, Yamamoto W, Nakabayashi S, Otsuji S, et al
    Streamlined reverse wire technique for the treatment of complex bifurcated lesions.
    Catheter Cardiovasc Interv. 2020;96:E287-E291.
    PubMed     Abstract available


  455. RADHOE SP, Schuurman AS, Ligthart JM, Witberg K, et al
    Two decades after coronary radiation therapy: A single center longitudinal clinical study.
    Catheter Cardiovasc Interv. 2020;96:E204-E212.
    PubMed     Abstract available


  456. FEMIA G, Faour A, Assad J, Sharma L, et al
    Comparing the clinical and prognostic impact of proximal versus nonproximal lesions in dominant right coronary artery ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Sep 1. doi: 10.1002/ccd.29245.
    PubMed     Abstract available


    August 2020
  457. D'ENTREMONT MA, Laferriere C, Berube S, Couture EL, et al
    The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
    Catheter Cardiovasc Interv. 2020 Aug 29. doi: 10.1002/ccd.29144.
    PubMed     Abstract available


  458. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    PubMed     Abstract available


  459. BOM MJ, Schumacher SP, Driessen RS, van Diemen PA, et al
    Non-invasive procedural planning using computed tomography-derived fractional flow reserve.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29210.
    PubMed     Abstract available


  460. SHAH H, Patel S, Solanki S, Wudexi I, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients undergoing percutaneous coronary intervention: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29184.
    PubMed     Abstract available


  461. VELAZQUEZ MARTIN M, Montero Cabezas JM, Huertas S, Nuche J, et al
    Clinical relevance of adding intravascular ultrasound to coronary angiography for the diagnosis of extrinsic left main coronary artery compression by a pulmonary artery aneurysm in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29194.
    PubMed     Abstract available


  462. LAFONT A, Sinnaeve PR, Cuisset T, Cook S, et al
    Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29159.
    PubMed     Abstract available


  463. CHIARITO M, Mehran R
    Drug-eluting stents in diabetic patients: Are we still treading water?
    Catheter Cardiovasc Interv. 2020;96:253-254.
    PubMed     Abstract available


  464. GOLDSTEIN JA, Hanson I
    Impella RP for treatment of right ventricular shock: Appropriate unloading never gets old.
    Catheter Cardiovasc Interv. 2020;96:382-383.
    PubMed     Abstract available


  465. CHANDRASEKHAR J, Dangas G, Baber U, Sartori S, et al
    Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI.
    Catheter Cardiovasc Interv. 2020;96:298-308.
    PubMed     Abstract available


  466. BENEDUCE A, Ferrante G, Ielasi A, Pivato CA, et al
    One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).
    Catheter Cardiovasc Interv. 2020;96:255-265.
    PubMed     Abstract available


  467. BAYON J, Santas-Alvarez M, Ocaranza-Sanchez R, Gonzalez-Juanatey C, et al
    Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?
    Catheter Cardiovasc Interv. 2020;96:E174-E176.
    PubMed     Abstract available


  468. XI Y, Chen J, Bi Y, Xie S, et al
    Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Catheter Cardiovasc Interv. 2020;96:E129-E141.
    PubMed     Abstract available


  469. BRIGUORI C, Tamburino C, Jessurun GAJ, Meyer-Gessner M, et al
    Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study.
    Catheter Cardiovasc Interv. 2020;96:E142-E148.
    PubMed     Abstract available


  470. PLOUMEN EH, Buiten RA, Kok MM, Doggen CJM, et al
    Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
    Catheter Cardiovasc Interv. 2020;96:E110-E118.
    PubMed     Abstract available


  471. KWON O, Lee JB, Ahn JM, Kang SJ, et al
    Clinical outcomes of contemporary drug-eluting stents in patients with and without diabetes mellitus: Multigroup propensity-score analysis using data from stent-specific, multicenter, prospective registries.
    Catheter Cardiovasc Interv. 2020;96:243-252.
    PubMed     Abstract available


  472. SACHEDINA AK, Ajluni SC, Jumean MF
    The use of a sentinel cerebral protection system during Impella CP removal in a patient with left ventricular thrombus.
    Catheter Cardiovasc Interv. 2020;96:504-506.
    PubMed     Abstract available


    July 2020
  473. BABAKHANI H, Sadeghipour P, Tashakori Beheshti A, Ghasemi M, et al
    Diagnostic accuracy of two-dimensional coronary angiographic-derived fractional flow reserve-Preliminary results.
    Catheter Cardiovasc Interv. 2020 Jul 27. doi: 10.1002/ccd.29150.
    PubMed     Abstract available


  474. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    PubMed     Abstract available


  475. FRACCARO C, Campante Teles R, Tchetche D, Saia F, et al
    Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29112.
    PubMed     Abstract available


  476. BUTMAN SM
    Revascularization for multivessel disease: Getting closer, but....
    Catheter Cardiovasc Interv. 2020;96:52.
    PubMed     Abstract available


  477. COSTELLO B, Krajcer Z
    Assessing atherothrombotic burden with optical coherence tomography analysis may facilitate post-PCI prognostication and antiplatelet therapy.
    Catheter Cardiovasc Interv. 2020;96:98-99.
    PubMed     Abstract available


  478. SRIDHARAN A, Kimmelstiel C
    Morphine in primary percutaneous coronary intervention-No pain, questionable gain.
    Catheter Cardiovasc Interv. 2020;96:89-90.
    PubMed     Abstract available


  479. CHENEY A, Dean LS
    State-of-the-art percutaneous coronary interventions applied to the treatment of bifurcation lesions: Are we there yet?
    Catheter Cardiovasc Interv. 2020;96:18-19.
    PubMed     Abstract available


  480. ARANZULLA TC, Musumeci G
    True caring is protecting who is at your side.
    Catheter Cardiovasc Interv. 2020;96:29-30.
    PubMed     Abstract available


  481. ZIMARINO M, Barbato E, Nakamura S, Radico F, et al
    The impact of the extent of side branch disease on outcomes following bifurcation stenting.
    Catheter Cardiovasc Interv. 2020;96:E84-E92.
    PubMed     Abstract available


  482. SHISHIDO K, Moriyama N, Hayashi T, Yokota S, et al
    The efficacy of modified jailed balloon technique for true bifurcation lesions.
    Catheter Cardiovasc Interv. 2020;96:20-28.
    PubMed     Abstract available


  483. IANNACCONE M, D'Ascenzo F, Gallone G, Mitomo S, et al
    Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes.
    Catheter Cardiovasc Interv. 2020;96:1-9.
    PubMed     Abstract available


  484. GRAY WA, Levy E, Bacharach JM, Metzger DC, et al
    Evaluation of a novel mesh-covered stent for treatment of carotid stenosis in patients at high risk for endarterectomy: 1-year results of the SCAFFOLD trial.
    Catheter Cardiovasc Interv. 2020;96:121-127.
    PubMed     Abstract available


  485. KUMAR K, Reddy S, Acharya D, Lotun K, et al
    Novel technique of performing multivessel PCI through an Impella sheath.
    Catheter Cardiovasc Interv. 2020;96:117-120.
    PubMed     Abstract available


  486. KUMAR G, Desai R, Gore A, Rahim H, et al
    Real world validation of the nonhyperemic index of coronary artery stenosis severity-Resting full-cycle ratio-RE-VALIDATE.
    Catheter Cardiovasc Interv. 2020;96:E53-E58.
    PubMed     Abstract available


  487. VO MN, Brilakis ES, Pershad A, Grantham JA, et al
    Modified subintimal transcatheter withdrawal: A novel technique for hematoma decompression to facilitate distal reentry during coronary chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2020;96:E98-E101.
    PubMed     Abstract available


  488. LIU J, Li L, Chen C, Wei J, et al
    Modified kissing balloon inflation associated with better results after Culotte stenting for bifurcation lesions: A bench test.
    Catheter Cardiovasc Interv. 2020;96:E34-E44.
    PubMed     Abstract available


  489. KATSIKIS A, Keeble TR, Davies JR, Jagathesan R, et al
    Contemporary management of stent thrombosis: Predictors of mortality and the role of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2020;96:E8-E16.
    PubMed     Abstract available


  490. CERRATO E, Barbero U, Quadri G, Ryan N, et al
    Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III st
    Catheter Cardiovasc Interv. 2020;96:E17-E26.
    PubMed     Abstract available


  491. CHAN YH, Cheng VYH, Wong CW, Lam CS, et al
    A simplified reverse wire technique using an angulated supercross microcatheter.
    Catheter Cardiovasc Interv. 2020;96:E93-E97.
    PubMed     Abstract available


  492. CASANA R, Tolva VS, Odero A Jr, Malloggi C, et al
    Carotid artery stenting is safe and effective for symptomatic patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020;96:129-135.
    PubMed     Abstract available


  493. MODOLO R, Kogame N, Komiyama H, Chichareon P, et al
    Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study.
    Catheter Cardiovasc Interv. 2020;96:10-17.
    PubMed     Abstract available


    June 2020
  494. NIKOLAKOPOULOS I, Choi JW, Alaswad K, Khatri JJ, et al
    Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2020 Jun 29. doi: 10.1002/ccd.29106.
    PubMed     Abstract available


  495. KAPUR NK, Hirst CS, Davila CD, Garcia R, et al
    Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29073.
    PubMed     Abstract available


  496. SATTLER M, Moscona J, Johnson PM, Madamanchi C, et al
    Resting Pd/Pa correlates with fractional flow reserve but not angiographic severity in calcified coronary arteries.
    Catheter Cardiovasc Interv. 2020 Jun 20. doi: 10.1002/ccd.29074.
    PubMed     Abstract available


  497. KARACSONYI J, Brilakis ES
    Percutaneous coronary intervention: The "oculosufficient" effect and how to overcome it.
    Catheter Cardiovasc Interv. 2020;95:1267-1268.
    PubMed     Abstract available


  498. GRINES CL, Tummala P, Marshall JJ
    STEMI in the cancer patient: Do not withhold primary PCI!
    Catheter Cardiovasc Interv. 2020;95:1275-1276.
    PubMed     Abstract available


  499. CONROTTO F, D'Ascenzo F, Piroli F, Franze A, et al
    Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29048.
    PubMed     Abstract available


    May 2020
  500. TABAZA L, Virk HUH, Janzer S, George JC, et al
    Robotic-assisted percutaneous coronary intervention in a COVID-19 patient.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28982.
    PubMed     Abstract available


  501. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    PubMed    


  502. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    PubMed     Abstract available


  503. HIGUCHI S, Kabeya Y, Nishina Y, Miura Y, et al
    Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28958.
    PubMed     Abstract available


  504. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    PubMed     Abstract available


  505. TOMMASO CL
    Stenting in unprotected left main coronary stenosis-"What no progress"?
    Catheter Cardiovasc Interv. 2020;95:1092-1093.
    PubMed     Abstract available


  506. JOLICOEUR EM, Henry TD
    The Robin Hood effect!
    Catheter Cardiovasc Interv. 2020;95:1109-1110.
    PubMed     Abstract available


  507. SAFIAN RD
    Invasive fractional flow reserve: Which technology is best?
    Catheter Cardiovasc Interv. 2020;95:1102-1103.
    PubMed     Abstract available


  508. HAUDE M, Lee SWL, Worthley SG, Silber S, et al
    The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.
    Catheter Cardiovasc Interv. 2020;95:1076-1084.
    PubMed     Abstract available


  509. BEYGUI F, Lemaitre A, Bignon M, Wain-Hobson J, et al
    A head-to-head comparison of three coronary fractional flow reserve measurement technologies: The fractional flow reserve-device study.
    Catheter Cardiovasc Interv. 2020;95:1094-1101.
    PubMed     Abstract available


  510. SHIBUTANI H, Fujii K, Matsumura K, Otagaki M, et al
    Differential influence of lesion length on fractional flow reserve in intermediate coronary lesions between each coronary artery.
    Catheter Cardiovasc Interv. 2020;95:E168-E174.
    PubMed     Abstract available


  511. TZANIS G, Palmisano A, Gallone G, Ponticelli F, et al
    The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris.
    Catheter Cardiovasc Interv. 2020;95:1104-1108.
    PubMed     Abstract available


  512. HANSON CA, Ragosta M
    Typical angina in a patient with Takayasu arteritis.
    Catheter Cardiovasc Interv. 2020;95:1129-1132.
    PubMed     Abstract available


  513. VAN ZANDVOORT LJC, van Bommel RJ, Masdjedi K, Tovar Forero MN, et al
    Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2020;95:1085-1091.
    PubMed     Abstract available


    April 2020
  514. AZZALINI L, Johal GS, Baber U, Bander J, et al
    Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28931.
    PubMed     Abstract available


  515. HARA H, Kogame N, Takahashi K, Modolo R, et al
    Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28898.
    PubMed     Abstract available


  516. THOMSON VS, Varghese MJ, Chacko ST, Varghese L, et al
    Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28897.
    PubMed     Abstract available


  517. MADDER RD, VanOosterhout S, Mulder A, Bush J, et al
    Network latency and long-distance robotic telestenting: Exploring the potential impact of network delays on telestenting performance.
    Catheter Cardiovasc Interv. 2020;95:914-919.
    PubMed     Abstract available


  518. ADACHI T, Sato A, Kuroki K, Terai T, et al
    Audiovisual telesupport system for cardiovascular catheter interventions: A preliminary report on the clinical implications.
    Catheter Cardiovasc Interv. 2020;95:906-910.
    PubMed     Abstract available


  519. YANG HM, Lim HS, Yoon MH, Seo KW, et al
    Usefulness of the trans-stent fractional flow reserve gradient for predicting clinical outcomes.
    Catheter Cardiovasc Interv. 2020;95:E123-E129.
    PubMed     Abstract available


    March 2020
  520. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    PubMed     Abstract available


  521. CHANDRASEKHAR J, Kerkmeijer LS, Kalkman DN, Sartori S, et al
    Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28853.
    PubMed     Abstract available


  522. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    PubMed     Abstract available


  523. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    PubMed     Abstract available


  524. DE GREGORIO J, Bailey SR
    ISCHEMIA from a clinicians perspective: Treating the patient or the investigator?
    Catheter Cardiovasc Interv. 2020;95:711-712.
    PubMed    


  525. ORR WB, Johnson MC, Abarbanell AM, Sintek M, et al
    Recanalization of an atretic intramural left main coronary artery after bypass surgery in a pediatric patient with anomalous aortic origin of the left main coronary artery arising from the right sinus of Valsalva.
    Catheter Cardiovasc Interv. 2020;95:739-742.
    PubMed     Abstract available


  526. D'AMICO G, Massussi M, Fraccaro C, Tarantini G, et al
    Coronary sinus reducer implantation in the middle cardiac vein for the treatment of refractory angina.
    Catheter Cardiovasc Interv. 2020;95:718-721.
    PubMed     Abstract available


  527. RAGHUNATHAN D, Hernandez N, Rajagopal K, Jumean M, et al
    Axillary Impella insertion under regional nerve block: A case report.
    Catheter Cardiovasc Interv. 2020;95:E108-E110.
    PubMed     Abstract available


  528. NAKAMURA S, Yamamoto T, Teng Y, Matsumoto S, et al
    Impact of intensively lowered low-density lipoprotein cholesterol on deferred lesion prognosis.
    Catheter Cardiovasc Interv. 2020;95:E100-E107.
    PubMed     Abstract available


  529. CHESTER RC, Mina SA, Lewis B, Zhang N, et al
    Radial artery access is under-utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI Registry.
    Catheter Cardiovasc Interv. 2020;95:675-683.
    PubMed     Abstract available


    February 2020
  530. KHEIRI B, Rao SV, Osman M, Simpson TF, et al
    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28800.
    PubMed     Abstract available


  531. AOI S, Baber U, Kovacic JC, Mehran R, et al
    Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28784.
    PubMed     Abstract available


  532. D'ASCENZO F, Gaido L, Bernardi A, Saglietto A, et al
    Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.
    Catheter Cardiovasc Interv. 2020;95:522-529.
    PubMed     Abstract available


  533. ALMALLA M, Kersten A, Altiok E, Marx N, et al
    Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:357-362.
    PubMed     Abstract available


  534. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Long-term effect of remote ischemic conditioning on infarct size and clinical outcomes in patients with anterior ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28760.
    PubMed     Abstract available


  535. PATEL N, Sharma A, Dalia T, Rali A, et al
    Vascular complications associated with percutaneous left ventricular assist device placement: A 10-year US perspective.
    Catheter Cardiovasc Interv. 2020;95:309-316.
    PubMed     Abstract available


  536. KOPS SA, Pangburn S, Barber BJ, Seckeler MD, et al
    Transcatheter treatment of acquired coronary sinus ostium atresia in a child with complex congenital heart disease.
    Catheter Cardiovasc Interv. 2020;95:E62-E65.
    PubMed     Abstract available


  537. IANNACCONE M, Colangelo S, Colombo F, Garbo R, et al
    Rotational atherectomy with the new RotaPro system over RG3 guidewire in subadventitial retrograde highly calcified CTO PCI.
    Catheter Cardiovasc Interv. 2020;95:242-244.
    PubMed     Abstract available


  538. FORD TJ, Khan A, Docherty KF, Jackson A, et al
    Sex differences in procedural and clinical outcomes following rotational atherectomy.
    Catheter Cardiovasc Interv. 2020;95:232-241.
    PubMed     Abstract available


  539. INIGUEZ A, Chevalier B, Richardt G, Neylon A, et al
    Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized cli
    Catheter Cardiovasc Interv. 2020;95:175-184.
    PubMed     Abstract available


  540. GOEL S, Pasam RT, Chava S, Sharma A, et al
    Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis.
    Catheter Cardiovasc Interv. 2020;95:216-223.
    PubMed     Abstract available


  541. JIA S, Guan C, Yuan J, Cao X, et al
    Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort.
    Catheter Cardiovasc Interv. 2020;95:206-215.
    PubMed     Abstract available


  542. LIU Y, Zhang Y, Li Y, Qi T, et al
    One-year clinical results of the NANO registry: A multicenter, prospective all-comers registry study in patients receiving implantation of a polymer-free sirolimus-eluting stent.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:658-664.
    PubMed     Abstract available


  543. BIAN L, Qiu M, Li Y, Xu X, et al
    Impact of extended dual antiplatelet therapy on clinical prognosis in acute coronary syndrome patients with intermediate or high ischemic risk defined by the GRACE score.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:665-673.
    PubMed     Abstract available


  544. WANG G, Ma G, Tao L, Yuan Z, et al
    Three-year follow up of biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: Pooled analysis of CREDIT II and CREDIT III trials.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:565-571.
    PubMed     Abstract available


  545. TIAN J, Tang YD, Qiao S, Su X, et al
    Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:587-597.
    PubMed     Abstract available


  546. ZHAO X, Guan C, Yuan J, Xie L, et al
    A modified predilation, sizing, and postdilation scoring system for patients undergoing metallic drug-eluting stent implantations.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:558-564.
    PubMed     Abstract available


    January 2020
  547. QUADROS A, Belli KC, de Paula JET, de Magalhaes Campos CAH, et al
    Chronic total occlusion percutaneous coronary intervention in Latin America.
    Catheter Cardiovasc Interv. 2020 Jan 28. doi: 10.1002/ccd.28744.
    PubMed     Abstract available


  548. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28742.
    PubMed     Abstract available


  549. ALAWAMI M, Thirunavukarasu S, Ahmed J, El-Omar M, et al
    Intravascular lithotripsy to treat an underexpanded coronary stent: 4-Month angiographic and OCT follow-up.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28738.
    PubMed     Abstract available


  550. ZHAO X, Li J, Xian Y, Chen J, et al
    Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28719.
    PubMed     Abstract available


  551. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    PubMed     Abstract available


  552. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-glutamyl transferase to albumin ratio as a novel predictor of bleeding events and mortality in patients after percutaneous coronary intervention: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28696.
    PubMed     Abstract available


  553. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


  554. COSTANTINI CR, Denk MA, De Macedo RM, Tarbine SG, et al
    Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28699.
    PubMed     Abstract available


  555. SONG L, Sun Z, Guan C, Yan H, et al
    First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes.
    Catheter Cardiovasc Interv. 2020 Jan 7. doi: 10.1002/ccd.28722.
    PubMed     Abstract available


    December 2019
  556. SHROFF AR, Gulati R, Drachman DE, Feldman DN, et al
    SCAI expert consensus statement update on best practices for transradial angiography and intervention.
    Catheter Cardiovasc Interv. 2019 Dec 27. doi: 10.1002/ccd.28672.
    PubMed     Abstract available


  557. GAO G, Zhang D, Song C, Xu H, et al
    Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28673.
    PubMed     Abstract available


  558. LI J, Li Y, Qiu M, Li Z, et al
    Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28653.
    PubMed     Abstract available


  559. YAN L, Li P, Wang Y, Han D, et al
    Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28652.
    PubMed     Abstract available


  560. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    PubMed     Abstract available


  561. NAZIR S, Ahuja KR, Donato A, Grande RD, et al
    Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28648.
    PubMed     Abstract available


  562. YAP J, Teo TY, Foong P, Binte Hussin N, et al
    A randomized controlled trial on the effectiveness of a portable patient education video prior to coronary angiography and angioplasty.
    Catheter Cardiovasc Interv. 2019 Dec 22. doi: 10.1002/ccd.28655.
    PubMed     Abstract available


  563. RIANGWIWAT T, Mumtaz T, Blankenship JC
    Barriers to use of radial access for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28619.
    PubMed     Abstract available


  564. XENOGIANNIS I, Choi JW, Alaswad K, Khatri JJ, et al
    Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28614.
    PubMed     Abstract available


    November 2019
  565. OMRAN J, Enezate T, Abdullah O, Al-Dadah A, et al
    Outcomes of fractional flow reserve-guided percutaneous coronary interventions in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28611.
    PubMed     Abstract available


  566. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    PubMed     Abstract available


  567. OKADA K, Hibi K, Matsushita K, Yagami H, et al
    Intravascular ultrasound radiofrequency signal analysis of blood speckles: Physiological assessment of intermediate coronary artery stenosis.
    Catheter Cardiovasc Interv. 2019 Nov 28. doi: 10.1002/ccd.28612.
    PubMed     Abstract available


  568. AMR BS, Lippmann M, Tobbia P, Isom N, et al
    Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions.
    Catheter Cardiovasc Interv. 2019 Nov 26. doi: 10.1002/ccd.28618.
    PubMed     Abstract available


  569. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    PubMed     Abstract available


  570. SULLIVAN AE, Nanna MG, Rao SV, Cantrell S, et al
    A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28535.
    PubMed     Abstract available


  571. ADAMS HSL, Rajani R, Hildick-Smith D, Redwood S, et al
    "Between a rock and the mitral valve space": Transcatheter mitral valve-in-valve implantation for paravalvular leak and refractory hemolysis complicated by circumflex coronary occlusion.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28573.
    PubMed     Abstract available


  572. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    PubMed     Abstract available


    October 2019
  573. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    PubMed     Abstract available


  574. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    PubMed     Abstract available


  575. YEOH J, Dworakowski R, Hill J, Byrne J, et al
    A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28521.
    PubMed     Abstract available


  576. POLETTI E, Azzalini L, Ayoub M, Ojeda S, et al
    Conventional vascular access site approach versus fully trans-wrist approach for chronic total occlusion percutaneous coronary intervention: a multicenter registry.
    Catheter Cardiovasc Interv. 2019 Oct 9. doi: 10.1002/ccd.28513.
    PubMed     Abstract available


    September 2019
  577. STAUDACHER DL, Schmitt C, Zirlik A, Zehender M, et al
    Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2019 Sep 11. doi: 10.1002/ccd.28495.
    PubMed     Abstract available


  578. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    PubMed     Abstract available


    August 2019
  579. PAGNOTTA PA, Sanz-Sanchez J, Regazzoli D, Ferrante G, et al
    One-stop-shop totally percutaneous approach for severe aortic and mitral regurgitation in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Aug 27. doi: 10.1002/ccd.28466.
    PubMed     Abstract available


  580. GOEL S, Pasam RT, Raheja H, Gotesman J, et al
    Left main percutaneous coronary intervention-Radial versus femoral access: A systematic analysis.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28451.
    PubMed     Abstract available


  581. DARKI A, Motiwala A, Bakhos L, Lewis BE, et al
    Technical success and long-term outcomes after anomalous right coronary artery stenting with cardiac computed tomography angiography correlation.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28453.
    PubMed     Abstract available


  582. POTTS J, Mohamed MO, Lopez Mattei JC, Iliescu CA, et al
    Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28432.
    PubMed     Abstract available


  583. KOGAME N, Chichareon P, De Wilder K, Takahashi K, et al
    Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28428.
    PubMed     Abstract available


  584. ROULE V, Schwob L, Lemaitre A, Bignon M, et al
    Residual atherothrombotic burden after primary percutaneous coronary intervention and myocardial reperfusion-An optical frequency domain imaging study.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28429.
    PubMed     Abstract available


  585. IANNACCONE M, Abdirashid M, Annone U, Saint-Hilary G, et al
    Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention: A network meta-analysis of randomized and propensity matching studies.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28410.
    PubMed     Abstract available


  586. DOSHI R, Patel K, Desai R, Patel P, et al
    Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28431.
    PubMed     Abstract available


  587. WATANABE H, Shiomi H, Morimoto T, Furukawa Y, et al
    Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420.
    PubMed     Abstract available


    July 2019
  588. FLAHERTY MP, Moses JW, Westenfeld R, Palacios I, et al
    Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Catheter Cardiovasc Interv. 2019 Jul 29. doi: 10.1002/ccd.28400.
    PubMed     Abstract available


  589. SAADAT N, Saadatagah S, Aghajani Nargesi A, Alidoosti M, et al
    Short-term safety and long-term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28396.
    PubMed     Abstract available


  590. LI Y, Tian F, Wang J, Xie M, et al
    Pseudoaneurysm of the non-coronary sinus of Valsalva: A rare complication of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28407.
    PubMed     Abstract available


  591. RAFEEDHEEN R, Agarwal SK, Meek JC, Uretsky BF, et al
    Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28399.
    PubMed     Abstract available


  592. KIRTANE AJ, Yeung AC, Ball M, Carr J, et al
    Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.
    Catheter Cardiovasc Interv. 2019 Jul 13. doi: 10.1002/ccd.28392.
    PubMed     Abstract available


    June 2019
  593. HE Y, Cheng XF, Wang K, Liu T, et al
    Predictive value of combining the SYNTAX score with reactive hyperemia index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 29. doi: 10.1002/ccd.28384.
    PubMed     Abstract available


  594. AL-KHADRA Y, Alraies MC, Darmoch F, Pacha HM, et al
    Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jun 28. doi: 10.1002/ccd.28383.
    PubMed     Abstract available


  595. HIRAI T, Jacob D, Main ML, Grantham JA, et al
    A case of robotic assisted percutaneous coronary intervention of the left main coronary artery in a patient with very late baffle stenosis after surgical correction of anomalous left coronary artery from the pulmonary artery.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28382.
    PubMed     Abstract available


  596. CHANDIRAMANI R, Chen H, Aoi S, Giustino G, et al
    Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369.
    PubMed     Abstract available


    May 2019
  597. BARBARAWI M, Kheiri B, Zayed Y, Barbarawi O, et al
    Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28280.
    PubMed     Abstract available


    April 2019
  598. TOVAR FORERO MN, van Zandvoort L, Masdjedi K, Diletti R, et al
    Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28304.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: